Gabapentin
Product Images NDC 50090-3353

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-3353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Capsules Usp 1)

This is a medical formula used to calculate the estimated glomerular filtration rate (eGFR) in adult patients. The formula involves subtracting the patient's age multiplied by 140 from their weight in kilograms and multiplying the result by 772. Serum creatinine level is also a factor in the calculation, with the value being adjusted by 0.85 for female patients. This formula is commonly used to screen for kidney function and assess the severity of kidney disease.*

FDA Label Image

Chem Structure (Gabapentin Capsules Usp 2)

FDA Label Image

10 (Gabapentin Capsules Usp 3)

FDA Label Image

10 (Gabapentin Capsules Usp 4)

FDA Label Image

10 (Gabapentin Capsules Usp 5)

The text provided appears to be a part of a figure caption showing the results of controlled PHN studies in terms of the proportion of patients who had a reduction in pain score. The text also includes some monetary values such as GBP 3600 and GBP 2400, which may pertain to the study expenses or costs of treatment. However, the text seems to be incomplete and lacks context to provide further insights. Therefore, a comprehensive description cannot be generated from the given text.*

FDA Label Image

Figure 4 (Gabapentin Capsules Usp 6)

FDA Label Image

Label Image (Lbl500903353)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.